本文へ移動
cccskills
無料GitHub で公開

fda-catalyst-medicines

CDER-track catalyst analysis for medicines: PDUFA target dates, AdCom votes, sNDA/sBLA label expansions, biosimilar interchangeability and 180-day exclusivity, Orange Book state, and CRL remediation timelines — enumerated, verified, and sized per event for any biotech/pharma ticker or watchlist.

インストール方法を見る

含まれるファイル(3)

  • SKILL.md8.2 KB
  • references/knowledge-frameworks.md5.1 KB
  • references/modes.md604 B

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Methodology inspired by publicly taught biotech catalyst frameworks; all text is an original paraphrase.

Defaults

ParameterDefault ValueRationale
forward_window_quarters4Standard catalyst window; extend to 8 on request
include_supersededfalseActive-only events by default; supersede chains on request
exclusivity_trackingtrueOrange Book and 180-day exclusivity state attached to launch-relevant events
holiday_labelingtrueHoliday-shifted weeks flagged on every calendar row
horizon_days180Default for get_upcoming_pdufa horizon

Preflight

Run canonical pre-flight per contracts/preflight.md. Include the X-Agentii-Trace header on every tool call per contracts/x-agentii-trace-header.md — carry the _run_id from your first tool result and name yourself (and your parent, if you were spawned). Confirm ticker resolution via search_companies before catalyst queries.

Triggers

  • "When is the PDUFA date for [drug/ticker]?"
  • "What AdCom meetings are coming up for [ticker]?"
  • "Has [drug]'s sNDA/sBLA label expansion been approved?"
  • "Which biosimilars have interchangeability designation, and when does 180-day exclusivity run?"
  • "What is [drug]'s Orange Book patent and exclusivity state?"
  • "How is [ticker]'s CRL remediation timeline shaping up?"
  • "Build a PDUFA/AdCom calendar for my pharma watchlist."
  • "Evaluate the approval odds for [drug] ahead of its AdCom."
  • "What label expansions are pending for [ticker] this year?"
  • "Which medicine decisions land this quarter?"
  • "How do biosimilar launches erode the reference product's share?"
  • "Which catalysts overlap with [ticker]'s earnings date?"

Production Grounding

  • CDER mechanics: NDA/BLA review tracks, PDUFA target dates, priority review, breakthrough designation, accelerated approval, CRL deficiency classes and the remediation reset, AdCom vote patterns.
  • Label expansions (sNDA/sBLA) are the commercial catalysts beyond first approval; Orange Book patent and exclusivity state sets the generic or biosimilar entry window.
  • Biosimilar timeline note: interchangeability plus 180-day exclusivity for the first interchangeable delays competing entry — and approval is not launch; commercial timing follows exclusivity expiry and patent-settlement terms.
  • Holiday-week labeling discipline: comps across holiday-shifted weeks are noisy; every calendar row carries its caveat, and holiday weeks are labeled explicitly.
  • Apply AdCom-style scrutiny axes when framing outcome odds; never fabricate dates, votes, or outcomes — annotate coverage gaps instead (per references/knowledge-frameworks.md).

Data Source Priority

  1. Structured catalyst data: get_upcoming_pdufa / get_pdufa_decision (pipeline.fda_calendar_event).
  2. AdCom and approval history: search_adcom_meetings / get_adcom_meeting; search_fda_approvals / get_fda_approval.
  3. Company and filing context: get_company_profile, search_documents, search_sec_filings; briefing docs via list_sources(source_type=adcom_briefing) + read_source_outline/read_source_pages with meeting slugs.
  4. Historical grounding: search_investment_cases (event_type=adcom_vote/pdufa_decision/crl/approval), search_by_analogue, search_investment_strategies (sectors=med).
  5. Earnings overlap: search_earnings_calendar / list_upcoming_earnings.

Methodology

Retrieval Scope

unstructured_document_search

Retrieval Strategy

  1. Resolve ticker(s) via search_companies; note primary drug/application names.
  2. Pull active PDUFA events (get_upcoming_pdufa, horizon_days=default); layer AdCom meetings and earnings dates.
  3. Per event: decision history (get_pdufa_decision by drug/application), approval record (get_fda_approval), label and Orange Book state.
  4. For AdCom events, retrieve briefing documents via list_sources + read_source_outline/read_source_pages using meeting slugs; apply scrutiny axes.
  5. Ground the play in knowledge: search_investment_cases / search_by_analogue with med filters; cite /v/ records.

Temporal Scope

See frontmatter temporal_scope block. Exclusivity windows may require looking back up to 8 quarters when requested.

Tool Allowlist

See frontmatter allowed_tools.

Protocol

  1. Ticker resolution
  2. Catalyst enumeration (PDUFA / AdCom / label expansion / exclusivity events)
  3. Per-event outcome framing (scrutiny axes + decision history)
  4. Historical analogue retrieval
  5. Calendar synthesis + exclusivity and risk flags

Modes

  • Watchlist (default, multi-ticker): one dated calendar with per-ticker sections, sorted by date.
  • Single ticker deep-dive: full event timeline, per-event probability framing, label and exclusivity state.
  • Event type: restrict to PDUFA / AdCom / label expansion / biosimilar milestones on request.
  • Exclusivity scan: Orange Book and 180-day windows as the launch-timing lens.

Tool Fallbacks

FailureFallback
get_upcoming_pdufa emptySearch filings (search_documents keyword PDUFA) + search_sec_filings 8-Ks; annotate coverage_gap
AdCom briefing path 404search_documents with source_institution filter; degrade to calendar metadata
Knowledge tools emptyProceed with structured data only; annotate knowledge coverage_gap
Orange Book state unknownFlag exclusivity window unavailable; never infer expiry dates

Output File

{ticker}/{YYYY-MM-DD_HHMM}_fda-catalyst-medicines_{affix}.md (watchlist: watchlist/{YYYY-MM-DD_HHMM}_fda-catalyst-medicines-calendar_{affix}.md)

Output Structure

  1. Executive Summary — highest-impact CDER-track catalysts in the window, 2-3 sentences
  2. Catalyst Calendar — dated table: date, ticker, event type, drug, application, holiday-week flag, expected-impact framing
  3. Per-Event Analysis — scrutiny-axes assessment (safety/statistics/subgroups/benefit-risk) + decision history
  4. Label & Exclusivity State — sNDA/sBLA status, Orange Book state, 180-day windows, biosimilar entry timing
  5. Historical Analogues — matched cases with /v/ citations and quantified outcomes
  6. Risk Assessment & Coverage Gaps — binary-risk sizing, overlap clusters, unverified or missing data

Error Handling

ErrorFallback
No PDUFA rowsFall back to earnings + AdCom + label events; annotate coverage_gap — never fabricate dates
Superseded datesActive-only by default; expose supersede chain via include_superseded=true
Ticker not in med universeResolve via CIK/drug-universe match; surface the classification gap

Memory Load

See contracts/memory-load.md.

Snapshot

See contracts/snapshot-synthesis.md.

Final Summary (TUI)

Include ### Key Citations block with 0-10 clickable /v/ URLs.

References

  • contracts/citation-and-memory.md
  • contracts/output-frontmatter-schema.md
  • contracts/memory-load.md
  • contracts/snapshot-synthesis.md
  • contracts/preflight.md
  • references/knowledge-frameworks.md

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

3-statement financial model, integrated IS BS CF, income statement projection, balance sheet forecast, cash flow statement, cross-statement balancing, financial model build, operating model, three statement model, integrated financial statements

日本語の概要は準備中です。原文の説明を表示しています。

agentii-ai/agentii-investment-intelligence2072026年9月29日 更新

Institutional-grade equity research skills for AI agents. 80 Claude-type skills across 14 verticals (equity-research-core, models-and-pitches, bio-pharm, scenarios, quantitative-analysis, idea-generation, options-derivatives, business-intelligence, industry-analysis, macro-strategy, portfolio-strategy, technical-analysis, risk-and-psychology, trading-as-business) powered by agentii.ai's agent-use-ready SEC filing data plane — SEC filings and 15K+ earnings call transcripts, 15.99M XBRL facts, and company profiles for 1,146+ US-public-equity tickers. Features the three-layer retrieval protocol (Document Discovery → Page Map → Deep Read, with deep-outline escalation) — measured, not asserted: 97.5% saved against a sequential read, and the page map itself is 10.0% of one (spec 062 T030, 2026-09-23) — server-side parallel multi-period search via search_cross_period, a full Excel/PPT generation pipeline with 3-tier office backend support, and the spec-046 governance layer (constitution, thesis and single-skill modes, mechanical gates, and a template-owned disclaimer on generated reports).

日本語の概要は準備中です。原文の説明を表示しています。

agentii-ai/agentii-investment-intelligence2072026年9月29日 更新

audit-xls

無料

Audit spreadsheet, formula error detection, hardcoded cell finder, cross-sheet reference audit, workbook auditor, Excel model audit, financial model QA, spreadsheet review, cell dependency trace, formula integrity check

日本語の概要は準備中です。原文の説明を表示しています。

agentii-ai/agentii-investment-intelligence2072026年9月29日 更新

Business model classification, business model analysis, structural analysis of how a company makes money, product offering decomposition, distribution channel analysis, customer segment analysis, revenue model identification, market sizing TAM SAM SOM, competitive positioning, business unit performance, management team & leadership analysis, what does the company sell, how does the company go to market, business model type platform service product, channel mix direct vs indirect, revenue concentration risk, CEO CFO executive backgrounds and changes

日本語の概要は準備中です。原文の説明を表示しています。

agentii-ai/agentii-investment-intelligence2072026年9月29日 更新

challenge

無料

Adversarial verification of research theses — cross-run/cross-thesis contradiction via the entity index, pre-mortem (Klarman/Kahneman: assume the loss already happened, reverse the path), inversion (Munger: invert, always invert), and wrong_if falsifiability review. ≈50-finding cap sorted by severity; content-derived finding IDs; incremental scoping with three backstops; lifecycle hooks at pillar-complete / thesis-complete / pre-reduction.

日本語の概要は準備中です。原文の説明を表示しています。

agentii-ai/agentii-investment-intelligence2072026年9月29日 更新

Chart pattern recognition, price action patterns, candlestick signal bars, pullback bar counting H1/H2/H3/H4, trend channels, micro channels, trading ranges, breakouts, major trend reversals 5-step sequence, wedges, double tops and bottoms, triangles, head and shoulders, climaxes, measured moves, support and resistance

日本語の概要は準備中です。原文の説明を表示しています。

agentii-ai/agentii-investment-intelligence2072026年9月29日 更新

agentii-ai のスキルをすべて見る

このスキルの問題を報告する